Tandem Diabetes Care

In an upcoming webinar, Dr. Brian Lake of Lake Endocrinology, and Rebecca Ellwood, PA, CDCES of Albany Med Health System will discuss how HCPs can help meet patients with type 2 diabetes where they are. The case-based conversation will explore how simplified bolusing strategies help ease the burden of mealtime bolusing and the additive impact of glucose-lowering medications and Control-IQ+ technology. Visit https://lnkd.in/gmsdNmqh to register today using program code TD26-0013. Important Safety Information: RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely. Safety info: https://lnkd.in/d3SmUSb

For Tanya Llera DeLong, Senior Director, Quality Assurance and Executive Sponsor of Latin Employees at Tandem (LET), inclusion starts with listening, learning, and creating space for people to feel valued. In this spotlight, Tanya shares how LET is helping build community, celebrate culture, and support employees across Tandem.

Join a team that's innovating every day for people living with diabetes. We're hiring a National Account Manager to lead market access strategy, payer partnerships, and access initiatives that help more people benefit from Tandem's insulin delivery technology. Apply today at the link below! + National Account Manager, Medicaid/Medicare: https://lnkd.in/eRbeG32S

New iOS update? We've got you covered. ✅ iOS 27 is compatible with the Tandem Mobi and Tandem t:slim mobile apps on currently compatible iPhone devices. For detailed compatibility information, please visit https://lnkd.in/e4zRE8a5. Individual symptoms, situations, circumstances, and results may vary. Important Safety Information: RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. Control-IQ+ technology is intended for use in pregnancy complicated by type 1 diabetes mellitus, provided the linked CGM system is suitable for use in pregnancy. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely. Safety info: https://lnkd.in/d3SmUSb.

Every system has setting adjustments that can impact mean glucose. For some systems, it's an adjustable target. For Control-IQ+ technology, the most impactful setting to adjust is Correction Factor. Check out today's episode of the Tandem Clinical Exchange Podcast to learn more about the impact of Correction Factor in Control-IQ+ technology. Watch the full episode here: https://lnkd.in/eA5XUEbD Important Safety Information: RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely. Safety info: https://lnkd.in/d3SmUSb.

Tandem Diabetes Care is advancing diabetes management during pregnancy. Tandem pumps, powered by Control-IQ+ technology, are the first and only AID system in the U.S. available for use during pregnancy. See how Tandem pumps can support your patients during pregnancy at https://lnkd.in/eHHgXpR4. Donovan LE, et al. JAMA. 2025;334(24):2176–2185. doi:10.1001/jama.2025.19578. Important Safety Information: RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. Control-IQ+ technology is intended for use in pregnancy complicated by type 1 diabetes mellitus, provided the linked CGM system is suitable for use in pregnancy. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely. Safety info: https://lnkd.in/d3SmUSb

Join Amy Rich, Sr. Manager of Medical Affairs for Tandem Diabetes Care, and Dr. Mahnaz Mellati of Seattle Endocrine for a case-based discussion on how Control-IQ+ technology supports tight glycemic goals in pregnancy and what those learnings reveal about increasing TITR and lowering mean glucose for non-pregnant patients. Visit https://lnkd.in/gmsdNmqh to register today using program code TD26-0012. Important Safety Information: RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. Control-IQ+ technology is intended for use in pregnancy complicated by type 1 diabetes mellitus, provided the linked CGM system is suitable for use in pregnancy. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely. Safety info: https://lnkd.in/d3SmUSb

Strong settings are the key to unlocking higher time in range with Control-IQ+ technology. Join Dr. Laurel Messer and Dr. Amy Rich on today’s episode of the Tandem Clinical Exchange Podcast to learn what settings have the biggest impact on mean glucose for patients using Control-IQ+. Watch the full episode here: https://lnkd.in/eA5XUEbD Important Safety Information: RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely. Safety info: https://lnkd.in/d3SmUSb.

A strong culture starts with supporting the whole person. Learn how Matt Barbian is helping bring wellness to life at Tandem through accessible resources, innovative programs, and a commitment to employee well-being.

Tandem Diabetes Care is the first and only system in the U.S. commercially available for use during pregnancy with type 1 diabetes. Stop by Booth #1313 to learn more about how Control-IQ+ technology allows users to spend more time in the pregnancy specific target range.¹ 1. Donovan LE, et al. JAMA. 2025;334(24):2176-2185. Important Safety Information: RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. Control-IQ+ technology is intended for use in pregnancy complicated by type 1 diabetes mellitus, provided the linked CGM system is suitable for use in pregnancy. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely. Safety info: https://lnkd.in/d3SmUSb.